Efficacy and Safety of Topical Tacrolimus (0.03%) in the Treatment Localized Vitiligo

Husain, Anwar; Alam, M.N.; Rahim, Rezaur; Joarder, Yasmin; Wahidujjaman,; Ferdous, Monalisa

doi:10.3329/medtoday.v29i1.33850

Cited by 2 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therapeutic options for vitiligo include: topical treatments, systemic treatment, phototherapy, excimer LASER, combination therapy, and surgical methods. Combination treatment using topical medications and noninvasive strategies are being increasingly studied in the management of resistant vitiligo patients …”

Section: Discussionmentioning

confidence: 99%

Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo

Yassa

Mahran

2019

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Background: Topical immunomodulators have been successfully used as monotherapy or in combination with other therapeutic modalities in treating vitiligo. To the best of our knowledge, no previous studies have evaluated the combination of tacrolimus 0.03% ointment and microdermabrasion as a therapeutic modality to hasten response time and improve repigmentation rate in vitiligo vulgaris. Aims:To explore the efficacy and safety of the combination of MDA and topical tacrolimus (0.03%) as a novel therapeutic approach for stable vitiligo vulgaris. Methods:Thirty-five patients with vitiligo were enrolled in this randomized placebo-controlled study. Three vitiligenous patches were chosen in each patient. The first lesion (A) was treated by tacrolimus 0.03% ointment, the second lesion (B) was treated by tacrolimus and microdermabrasion, and the third lesion (C) was treated by petrolatum as a placebo. Treatment course was 3 months, and follow-up was done for three extra months. Vitiligenous patches were assessed at baseline and monthly for 6 months.Results: Moderate to excellent response was observed in 65.7% of lesions B, compared with 25.8% of lesions A (P = .001). Improvement in VASI score was significantly better in patients treated by the combination therapy (P = .000). Disease duration has a negative impact on therapeutic response. Patients were more satisfied with the combination treatment. Conclusion:Microdermabrasion combined with tacrolimus 0.03% ointment represents a new therapeutic option for the treatment of vitiligo which appears to be an easy, safe, and effective. K E Y W O R D Simmunomodulators, microdermabrasion, placebo, tacrolimus, vitiligo

show abstract

Section: Discussionmentioning

confidence: 99%